Bicolor

Bicolor

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Biocolor is a specialized provider of research-use-only assay kits for quantifying extracellular matrix components, serving a global academic and industrial research market. The company's core value proposition lies in its user-friendly, dye-based colorimetric assays that simplify complex biochemical quantification, enabling researchers to focus on their core work. With products cited in thousands of peer-reviewed publications, Biocolor has established a trusted brand in niche research communities. It operates a straightforward business model of manufacturing and distributing kits directly and through a global distributor network.

DiagnosticsMedical Devices

Technology Platform

Proprietary dye-based colorimetric detection reagents formulated for selective, stoichiometric binding to specific extracellular matrix biomolecules (e.g., collagen, elastin, sGAG), enabling quantification via standard spectrophotometry.

Opportunities

Growing research into the extracellular matrix in fields like regenerative medicine, cancer, and cosmetics drives sustained demand for reliable quantification tools.
The company's strong citation record provides powerful peer validation to capture new researchers.
Expanding applications into emerging areas like 3D bioprinting and organoid research present new market segments.

Risk Factors

Competition from larger life science reagent corporations with greater R&D and marketing resources poses a constant threat.
Technological disruption by more advanced analytical methods (e.g., multiplex immunoassays, mass spectrometry) could erode market share for some applications.
The company's reliance on a niche research market makes it vulnerable to shifts in scientific funding priorities.

Competitive Landscape

Biocolor competes in the specialized niche of ECM quantification kits against a mix of other specialty reagent providers and broad-line life science suppliers (e.g., Thermo Fisher, Abcam). Its primary competitive advantages are its deep specialization, user-friendly kit design, and established reputation in the literature. Competition is based on assay performance, specificity, ease-of-use, price, and the quality of technical support.